Royal Fund Management’s Abiomed Inc ABMD Stock Holding History

Royal Fund Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-475	Closed	-$68K	–	617
2020 Q1	$68K	Hold	475	–	–	0.03%	207
2019 Q4	$81K	Hold	475	–	–	0.02%	209
2019 Q3	$84K	Hold	475	–	–	0.02%	199
2019 Q2	$123K	Hold	475	–	–	0.04%	167
2019 Q1	$135K	Hold	475	–	–	0.04%	148
2018 Q4	$154K	Hold	475	–	–	0.06%	125
2018 Q3	$213K	Sell	475 -25	-5%	-$9.86K	0.07%	114
2018 Q2	$204K	Hold	500	–	–	0.07%	111
2018 Q1	$145K	Hold	500	–	–	0.05%	131
2017 Q4	$93K	Hold	500	–	–	0.03%	167
2017 Q3	$84K	Hold	500	–	–	0.03%	132
2017 Q2	$71K	Hold	500	–	–	0.03%	134
2017 Q1	$62K	Hold	500	–	–	0.03%	140
2016 Q4	$56K	Buy	+500	New	+$57.9K	0.03%	139

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Royal Fund Management's ABMD Position: Q2 2020 in Review

Royal Fund Management sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 475 shares — an estimated $68K sold.

Royal Fund Management first reported a position in ABMD in Q4 2016 and held it in 14 quarters. The position peaked at $213K in Q3 2018. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

Royal Fund Management reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
Royal Fund Management sold 475 Abiomed Inc shares in Q2 2020, an estimated $68K.
Royal Fund Management first reported a position in Abiomed Inc in Q4 2016 and held it in 14 quarters.
Royal Fund Management's Abiomed Inc position peaked at $213K in Q3 2018.
460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.